-
1
-
-
0033128807
-
Statistics notes: Treatment allocation in controlled trials: why randomise?
-
Altman D.G., and Bland J.M. Statistics notes: Treatment allocation in controlled trials: why randomise?. Br Med J 318 7192 (1999) 1209
-
(1999)
Br Med J
, vol.318
, Issue.7192
, pp. 1209
-
-
Altman, D.G.1
Bland, J.M.2
-
2
-
-
58049217470
-
Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer
-
Mauri D., Polyzos N.P., Salanti G., Pavlidis N., and Ioannidis J.P.A. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst 100 24 (2008) 1780-1791
-
(2008)
J Natl Cancer Inst
, vol.100
, Issue.24
, pp. 1780-1791
-
-
Mauri, D.1
Polyzos, N.P.2
Salanti, G.3
Pavlidis, N.4
Ioannidis, J.P.A.5
-
3
-
-
0013573468
-
The role of statistics in the design and evaluation of trials in cancer medicine
-
Veronesi U., and Bonadonna G. (Eds), Academic Press, Orlando
-
Zelen M. The role of statistics in the design and evaluation of trials in cancer medicine. In: Veronesi U., and Bonadonna G. (Eds). Clinical trials in cancer medicine (1985), Academic Press, Orlando 561-568
-
(1985)
Clinical trials in cancer medicine
, pp. 561-568
-
-
Zelen, M.1
-
4
-
-
34248359393
-
The dangers of "cross-trial" and "cross-retrospective experience" comparisons
-
Markman M. The dangers of "cross-trial" and "cross-retrospective experience" comparisons. Cancer 109 (2007) 1929-1932
-
(2007)
Cancer
, vol.109
, pp. 1929-1932
-
-
Markman, M.1
-
5
-
-
0023617472
-
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies
-
Coates A., Gebski V., Bishop J., et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. New Engl J Med 317 24 (1987) 1490-1495
-
(1987)
New Engl J Med
, vol.317
, Issue.24
, pp. 1490-1495
-
-
Coates, A.1
Gebski, V.2
Bishop, J.3
-
6
-
-
0344606138
-
Quality of life with single agent mitozantrone or combination chemotherapy for advanced breast cancer, a randomised trial
-
Simes R., Gebski V., Coates A., et al. Quality of life with single agent mitozantrone or combination chemotherapy for advanced breast cancer, a randomised trial. Proc Am Soc Clin Oncol 13 (1994) 73
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 73
-
-
Simes, R.1
Gebski, V.2
Coates, A.3
-
7
-
-
34548228450
-
A randomized trial of capecitabine given intermittently versus continuously versus classical CMF as first line chemotherapy for women with advanced breast cancer unsuited to more intensive treatment
-
Stockler M., Sourjina T., Harvey V., et al. A randomized trial of capecitabine given intermittently versus continuously versus classical CMF as first line chemotherapy for women with advanced breast cancer unsuited to more intensive treatment. Breast Cancer Res Treat 100 (2007) S278
-
(2007)
Breast Cancer Res Treat
, vol.100
-
-
Stockler, M.1
Sourjina, T.2
Harvey, V.3
-
8
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller A., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 1 (1981) 207-214
-
(1981)
Cancer
, vol.47
, Issue.1
, pp. 207-214
-
-
Miller, A.1
Hoogstraten, B.2
Staquet, M.3
Winkler, A.4
-
9
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 3 (2000) 205-216
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
10
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 282 (1958) 457-481
-
(1958)
J Am Stat Assoc
, vol.53
, Issue.282
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
11
-
-
0000336139
-
Regression models and life-tables
-
Cox D.R. Regression models and life-tables. J Roy Stat Soc 34 2 (1972) 187-220
-
(1972)
J Roy Stat Soc
, vol.34
, Issue.2
, pp. 187-220
-
-
Cox, D.R.1
-
13
-
-
0037301972
-
Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor
-
Chang J., Clark G., Allred D., et al. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 97 (2003) 545-553
-
(2003)
Cancer
, vol.97
, pp. 545-553
-
-
Chang, J.1
Clark, G.2
Allred, D.3
-
14
-
-
0035138906
-
Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
-
Ryberg M., Nielsen D., Osterlind K., Skovsgaard T., and Dombernowsky P. Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. Ann Oncol 12 1 (2001) 81-87
-
(2001)
Ann Oncol
, vol.12
, Issue.1
, pp. 81-87
-
-
Ryberg, M.1
Nielsen, D.2
Osterlind, K.3
Skovsgaard, T.4
Dombernowsky, P.5
-
15
-
-
56749175264
-
Prognostic factors in 1038 women with metastatic breast cancer
-
Largillier R., Ferrero J.-M., Doyen J., et al. Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol (2008) mdn424
-
(2008)
Ann Oncol
-
-
Largillier, R.1
Ferrero, J.-M.2
Doyen, J.3
-
16
-
-
26444607816
-
Survival of metastatic breast carcinoma patients over a 20-year period
-
Gennari A., Conte P., Rosso R., Orlandini C., and Bruzzi P. Survival of metastatic breast carcinoma patients over a 20-year period. Cancer 104 8 (2005) 1742-1750
-
(2005)
Cancer
, vol.104
, Issue.8
, pp. 1742-1750
-
-
Gennari, A.1
Conte, P.2
Rosso, R.3
Orlandini, C.4
Bruzzi, P.5
-
17
-
-
0021050287
-
Multivariate analysis of prognostic factors in metastatic breast cancer
-
Hortobagyi G., Smith T., Legha S., et al. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1 (1983) 776-786
-
(1983)
J Clin Oncol
, vol.1
, pp. 776-786
-
-
Hortobagyi, G.1
Smith, T.2
Legha, S.3
-
18
-
-
0031830823
-
Construction and validation of a practical prognostic index for patients with metastatic breast cancer
-
Yamamoto N., Watanabe T., Katsumata N., et al. Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol 16 7 (1998) 2401-2408
-
(1998)
J Clin Oncol
, vol.16
, Issue.7
, pp. 2401-2408
-
-
Yamamoto, N.1
Watanabe, T.2
Katsumata, N.3
-
19
-
-
0031038467
-
An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting
-
Jantunen I.T., Kataja V.V., and Muhonen T.T. An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer 33 1 (1997) 66-74
-
(1997)
Eur J Cancer
, vol.33
, Issue.1
, pp. 66-74
-
-
Jantunen, I.T.1
Kataja, V.V.2
Muhonen, T.T.3
-
20
-
-
0027517374
-
Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group
-
Seshadri R., Firgaira F., Horsfall D., et al. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol 11 10 (1993) 1936-1942
-
(1993)
J Clin Oncol
, vol.11
, Issue.10
, pp. 1936-1942
-
-
Seshadri, R.1
Firgaira, F.2
Horsfall, D.3
-
21
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon D., Godolphin W., Jones L., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 4905 (1989) 707-712
-
(1989)
Science
, vol.244
, Issue.4905
, pp. 707-712
-
-
Slamon, D.1
Godolphin, W.2
Jones, L.3
-
22
-
-
33947645465
-
Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?
-
Dunkler D., Michiels S., and Schemper M. Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?. Eur J Cancer 43 4 (2007) 745-751
-
(2007)
Eur J Cancer
, vol.43
, Issue.4
, pp. 745-751
-
-
Dunkler, D.1
Michiels, S.2
Schemper, M.3
-
23
-
-
42949145995
-
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
-
Burzykowski T., Buyse M., Piccart-Gebhart M.J., et al. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer. J Clin Oncol 26 12 (2008) 1987-1992
-
(2008)
J Clin Oncol
, vol.26
, Issue.12
, pp. 1987-1992
-
-
Burzykowski, T.1
Buyse, M.2
Piccart-Gebhart, M.J.3
-
24
-
-
53149130962
-
Progression-free survival as a surrogate endpoint in advanced breast cancer
-
Miksad R.A., Zietemann V., Gothe R., et al. Progression-free survival as a surrogate endpoint in advanced breast cancer. Int J Tech Assess Health Care 24 04 (2008) 371-383
-
(2008)
Int J Tech Assess Health Care
, vol.24
, Issue.4
, pp. 371-383
-
-
Miksad, R.A.1
Zietemann, V.2
Gothe, R.3
-
25
-
-
0037374008
-
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses
-
Song F., Altman D., Glenny A., and Glenny J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. Br Med J 326 7387 (2003) 472-477
-
(2003)
Br Med J
, vol.326
, Issue.7387
, pp. 472-477
-
-
Song, F.1
Altman, D.2
Glenny, A.3
Glenny, J.4
-
26
-
-
0020045659
-
Randomized versus historical controls for clinical trials
-
Sacks H., Chalmers T., and Smith H. Randomized versus historical controls for clinical trials. Am J Med 72 (1981) 233-240
-
(1981)
Am J Med
, vol.72
, pp. 233-240
-
-
Sacks, H.1
Chalmers, T.2
Smith, H.3
-
27
-
-
0032585188
-
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
-
Kunz R., and Oxman A. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. Br Med J 317 (1998) 1185-1190
-
(1998)
Br Med J
, vol.317
, pp. 1185-1190
-
-
Kunz, R.1
Oxman, A.2
-
28
-
-
24644519961
-
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the italian tamoxifen anastrozole trial
-
Boccardo F., Rubagotti A., Puntoni M., et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the italian tamoxifen anastrozole trial. J Clin Oncol 23 22 (2005) 5138-5147
-
(2005)
J Clin Oncol
, vol.23
, Issue.22
, pp. 5138-5147
-
-
Boccardo, F.1
Rubagotti, A.2
Puntoni, M.3
-
29
-
-
69049113989
-
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
-
The BIG 1-98 Collaborative Group. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New Engl J Med 361 8 (2009) 766-776
-
(2009)
New Engl J Med
, vol.361
, Issue.8
, pp. 766-776
-
-
The BIG 1-98 Collaborative Group1
-
30
-
-
33748563196
-
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel
-
Ozols R., Bookman M., du Bois A., et al. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Gynecol Oncol 103 1 (2006) 1-6
-
(2006)
Gynecol Oncol
, vol.103
, Issue.1
, pp. 1-6
-
-
Ozols, R.1
Bookman, M.2
du Bois, A.3
-
31
-
-
33847152253
-
When are randomised trials unnecessary? Picking signal from noise
-
Glasziou P., Chalmers I., Rawlins M., and McCulloch P. When are randomised trials unnecessary? Picking signal from noise. Br Med J 334 7589 (2007) 349-351
-
(2007)
Br Med J
, vol.334
, Issue.7589
, pp. 349-351
-
-
Glasziou, P.1
Chalmers, I.2
Rawlins, M.3
McCulloch, P.4
-
32
-
-
66749086365
-
The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
-
Howick J., Glasziou P., and Aronson J.K. The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?. J Roy Soc Med 102 5 (2009) 186-194
-
(2009)
J Roy Soc Med
, vol.102
, Issue.5
, pp. 186-194
-
-
Howick, J.1
Glasziou, P.2
Aronson, J.K.3
|